243 related articles for article (PubMed ID: 20153005)
21. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
[TBL] [Abstract][Full Text] [Related]
22. Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors.
Matheeussen V; Lambeir AM; Jungraithmayr W; Gomez N; Mc Entee K; Van der Veken P; Scharpé S; De Meester I
Clin Chim Acta; 2012 Feb; 413(3-4):456-62. PubMed ID: 22093941
[TBL] [Abstract][Full Text] [Related]
23. Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme.
Diez-Torrubia A; Cabrera S; de Castro S; García-Aparicio C; Mulder G; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
Eur J Med Chem; 2013; 70():456-68. PubMed ID: 24185376
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
Waxman DJ; Ram PA; Pampori NA; Shapiro BH
Mol Pharmacol; 1995 Nov; 48(5):790-7. PubMed ID: 7476908
[TBL] [Abstract][Full Text] [Related]
25. Application of the dipeptidyl peptidase IV (DPPIV/CD26) based prodrug approach to different amine-containing drugs.
Diez-Torrubia A; García-Aparicio C; Cabrera S; De Meester I; Balzarini J; Camarasa MJ; Velázquez S
J Med Chem; 2010 Jan; 53(2):559-72. PubMed ID: 20000418
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid-dependency of increased adiposity in a model of hypothalamic obesity.
Perelló M; Moreno G; Gaillard RC; Spinedi E
Neuro Endocrinol Lett; 2004; 25(1-2):119-26. PubMed ID: 15159695
[TBL] [Abstract][Full Text] [Related]
27. Dipeptidyl peptidase IV (DPPIV/CD26)-based prodrugs of hydroxy-containing drugs.
Diez-Torrubia A; Cabrera S; Lambeir AM; Balzarini J; Camarasa MJ; Velázquez S
ChemMedChem; 2012 Apr; 7(4):618-28. PubMed ID: 22307932
[TBL] [Abstract][Full Text] [Related]
28. Effect of fasting and refeeding on duodenal alkaline phosphatase activity in monosodium glutamate obese rats.
Racek L; Lenhardt L; Mozes S
Physiol Res; 2001; 50(4):365-72. PubMed ID: 11551142
[TBL] [Abstract][Full Text] [Related]
29. Central but not peripheral glucoprivation is impaired in monosodium glutamate-treated rats.
de Andrade IS; Gonzalez JC; Hirata AE; Carneiro G; Amado D; Cavalheiro EA; Dolnikoff MS
Neurosci Lett; 2006 May; 398(1-2):6-11. PubMed ID: 16406310
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD26 and its association with dipeptidyl peptidase IV activity in lymphocytes of type 2 diabetes patients.
Bellé LP; Bitencourt PE; de Bona KS; Zanette RA; Moresco RN; Moretto MB
Cell Biochem Biophys; 2011 Nov; 61(2):297-302. PubMed ID: 21614532
[TBL] [Abstract][Full Text] [Related]
31. Altered behavior of adult obese rats by monosodium l-glutamate neonatal treatment is related to hypercorticosteronemia and activation of hypothalamic ERK1 and ERK2.
Guimarães ED; de Caires Júnior LC; Musso CM; Macedo de Almeida M; Gonçalves CF; Pettersen KG; Paes ST; González Garcia RM; de Freitas Mathias PC; Torrezan R; Mourao-Júnior CA; Andreazzi AE
Nutr Neurosci; 2017 Apr; 20(3):153-160. PubMed ID: 25683673
[TBL] [Abstract][Full Text] [Related]
32. Novel aspects of cellular action of dipeptidyl peptidase IV/CD26.
Ansorge S; Nordhoff K; Bank U; Heimburg A; Julius H; Breyer D; Thielitz A; Reinhold D; Täger M
Biol Chem; 2011 Mar; 392(3):153-68. PubMed ID: 21194362
[TBL] [Abstract][Full Text] [Related]
33. Sulphostin, a novel inhibitor of dipeptidyl peptidases IV (DPPIV) that stimulates hematopoiesis in mice.
Abe M; Abe F; Nishimura C; Ichimura E; Ogasawara A; Ichinei M; Muraoka Y; Saino T
J Antibiot (Tokyo); 2005 Feb; 58(2):111-7. PubMed ID: 15835723
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
[TBL] [Abstract][Full Text] [Related]
35. Involvement of dipeptidyl peptidase IV in extravillous trophoblast invasion and differentiation.
Sato Y; Fujiwara H; Higuchi T; Yoshioka S; Tatsumi K; Maeda M; Fujii S
J Clin Endocrinol Metab; 2002 Sep; 87(9):4287-96. PubMed ID: 12213886
[TBL] [Abstract][Full Text] [Related]
36. Obese patients have higher circulating protein levels of dipeptidyl peptidase IV.
Stengel A; Goebel-Stengel M; Teuffel P; Hofmann T; Buße P; Kobelt P; Rose M; Klapp BF
Peptides; 2014 Nov; 61():75-82. PubMed ID: 25219943
[TBL] [Abstract][Full Text] [Related]
37. Dipeptidyl peptidase IV (DPPIV) enzyme activity on immature T-cell line R1.1 is down-regulated by dynorphin-A(1-17) as a non-substrate inhibitor.
Gabrilovac J; Abramić M; Uzarević B; Andreis A; Poljak L
Life Sci; 2003 May; 73(2):151-66. PubMed ID: 12738031
[TBL] [Abstract][Full Text] [Related]
38. Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema.
Byrd JB; Shreevatsa A; Putlur P; Foretia D; McAlexander L; Sinha T; Does MD; Brown NJ
J Allergy Clin Immunol; 2007 Aug; 120(2):403-8. PubMed ID: 17531305
[TBL] [Abstract][Full Text] [Related]
39. Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis.
Tasic T; Bäumer W; Schmiedl A; Schwichtenhövel F; Pabst R; Raap U; von Hörsten S; Stephan M
Clin Exp Allergy; 2011 Aug; 41(8):1098-107. PubMed ID: 21672052
[TBL] [Abstract][Full Text] [Related]
40. Extreme reduction of dipeptidyl peptidase IV activity in F344 rat substrains is associated with various behavioral differences.
Karl T; Hoffmann T; Pabst R; von Hörsten S
Physiol Behav; 2003 Oct; 80(1):123-34. PubMed ID: 14568317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
